Live Antibody News with Latest Updates

Live antibody news and developments with the latest updates. Check out current antibody news stories and find out what happened, what is going on with antibody. Recent news updates about antibody
Jab-free dengue immunity could be just a click away
Statement from Chief Public Health Officer of Canada on May 13, 2021
Study finds mechanism leading to herceptin resistance and Rx approach to reverse it
Dialysis patients do not develop adequate antibodies with one dose of SARS-CoV-2 vaccine
‘key’ to new COVID-19 vaccine development
3D printing lays foundation for a new range of diagnostic tests
Magnetic microbead mixing to speed up molecular testing
Researchers Reveal Novel Mechanism Controlling TH9-mediated Cancer Immunotherapy
Protected by nanobrushes
Collie COVID-19 case confirmed as historical
How a SARS-CoV-2 variant sacrifices tight binding for antibody evasion
Researchers to study impact of IBD meds on COVID vaccine
New drug is gamechanger in psoriasis treatment
Scientists uncover a molecule that can help coronavirus escape antibodies
Scientists unmask new neutralizing antibody target on SARS-CoV-2 spike protein
Simulations reveal how dominant SARS-CoV-2 strain binds to host, succumbs to antibodies
Large Molecules Transported into Living Cells: Researchers Achieve Breakthrough into Cell Interior
CSL’s Plasma Protein Purification Challenge opens
Certain Cancer Patients at Risk of COVID-19 Vaccine Failure
Brain disease transmitted by tick bites may be treatable
Reverse-order heart-liver transplant helps prevent rejection for highly sensitized patients
Pentagon Awards $53.7 Million Contract to Ortho Clinical Diagnostics
New drug to regenerate lost teeth
NIST Puts New Biopharmaceutical Quality Control Method to Test
First FDA approval of CAR T-cell therapy for multiple myeloma marks milestone for patients
Joint FDA Advisory Committee Votes on Application for Tanezumab for Treatment of Osteoarthritis Pain
Volunteer register for new trials to prevent Alzheimer’s disease
New method targets disease-causing proteins for destruction
PHE study shows three-quarters of over-70s have COVID-19 antibodies
Signaling Research for Kids
Durham-based supercomputer helps tackle Covid
NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies
Solving a Genetic Mystery at Heart of COVID-19 Pandemic
Ludwig Johns Hopkins researchers devise new strategy for cancer immunotherapy
Fewer than 1 in 5 university students had COVID-19 by end of autumn term
UniSA researchers targeting a new treatment for pancreatic cancer
An mRNA vaccine for cancer immunotherapy
Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab
Toowoomba ceramicist explores body forms in debut solo exhibition
Anti-cancer drug’s mode of operation deciphered
UConn Health Researchers Track COVID-19 Immunity
New methods for exploring dark matter of biology
Intranasal influenza vaccine spurs strong immune response in Phase 1 study
Revolutionary eye drop trial starts for common eye diseases
New MUSC trials could help give more COVID-19 vaccine choices
Gut microbiota reveals whether drug therapies work in inflammatory bowel diseases
A Patient-Powered Registry Boosts Study of a Rare Disease
Continuous monitoring of proteins a game-changer for patients with rapidly deteriorating conditions